Pancreatic Cancer Drug

U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer. The Food and Drug Administration granted approval Wednesday to the first-of-a-kind pill from Revolution Medicines. The drug uses a new approach to block a protein that fuels tumor growth in the vast majority of pancreatic cancer cases. Patients taking the drug nearly doubled their survival time in a company study. Experts say the treatment will likely revamp their approach to the disease and other hard-to-treat cancers. Other companies are researching drugs with similar actions.